Heart Failure

badge 1 badge 2

Le Bonheur Children’s Heart Institute offers the most advanced treatment options for children, adolescents and adults with complex and uncorrectable congenital or acquired heart disease, including cardiomyopathy.

Heart failure is a term that means the heart does not sufficiently pump enough blood throughout the body. Treatment can vary from medication to the implantation of devices, like a ventricular assist device (VAD), and heart transplantation.

Why Le Bonheur Children’s?

  • Our Heart Transplant program, led by Medical Director Jeffrey Towbin, MD, and Surgical Director Umar Boston, MD, is approved by the United Network for Organ Sharing (UNOS).
  • Our Heart Institute received the highest quality rating of three stars from The Society of Thoracic Surgery (STS). The three-star rating is awarded for excellence in cardiac surgery outcomes in a four-year period.
  • The average survival rates for the majority of heart surgeries at Le Bonheur are considerably higher than the national average.

Our team

The program offers individualized care by a multidisciplinary team that includes:

  • pediatric cardiologists
  • pediatric cardiovascular surgeons
  • cardiac intensivists
  • electrophysiologists
  • specialists in cardiac MRI, ECHO and catheterization
  • pharmacists
  • nurse practitioners and nurses

Meet our team members.


We are committed to finding new and better ways to treat children with uncorrectable congenital heart disease. Research focuses include:

  • Genetic testing and gene discovery
    Our researchers are working to discover more about the mechanisms and genes responsible for cardiomyopathy and other causes of heart failure in children.
  • Future treatments in children with cardiomyopathy and heart failure
    We are working to learn more about transplant rejection and viral causes of myocarditis, cardiomyopathies and transplant coronary disease.

Contact Heart Institute